These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20885081)

  • 21. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M
    Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of biphenyltrienes as probes for beta-amyloid plaques.
    Zhuang ZP; Kung MP; Kung HF
    J Med Chem; 2006 May; 49(9):2841-4. PubMed ID: 16640346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
    Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
    J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging.
    Kaide S; Ono M; Watanabe H; Shimizu Y; Nakamoto Y; Togashi K; Yamaguchi A; Hanaoka H; Saji H
    Bioorg Med Chem; 2018 Jul; 26(12):3352-3358. PubMed ID: 29751990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
    Sabri O; Sabbagh MN; Seibyl J; Barthel H; Akatsu H; Ouchi Y; Senda K; Murayama S; Ishii K; Takao M; Beach TG; Rowe CC; Leverenz JB; Ghetti B; Ironside JW; Catafau AM; Stephens AW; Mueller A; Koglin N; Hoffmann A; Roth K; Reininger C; Schulz-Schaeffer WJ;
    Alzheimers Dement; 2015 Aug; 11(8):964-74. PubMed ID: 25824567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid.
    Nabuurs RJ; Natté R; de Ronde FM; Hegeman-Kleinn I; Dijkstra J; van Duinen SG; Webb AG; Rozemuller AJ; van Buchem MA; van der Weerd L
    J Alzheimers Dis; 2013; 34(4):1037-49. PubMed ID: 23340037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?
    Moghbel MC; Saboury B; Basu S; Metzler SD; Torigian DA; Långström B; Alavi A
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):202-8. PubMed ID: 22009379
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel imaging probe for in vivo detection of neuritic and diffuse amyloid plaques in the brain.
    Okamura N; Suemoto T; Shiomitsu T; Suzuki M; Shimadzu H; Akatsu H; Yamamoto T; Arai H; Sasaki H; Yanai K; Staufenbiel M; Kudo Y; Sawada T
    J Mol Neurosci; 2004; 24(2):247-55. PubMed ID: 15456938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.
    Tu P; Fu H; Cui M
    Expert Opin Ther Pat; 2015 Apr; 25(4):413-23. PubMed ID: 25746836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.